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Summary 
Two interleukin-2 receptor-dependent signaling path- 
ways have thus far been identified: the c-fos/c-jun in- 
duction pathway mediated by src family protein- 
tyrosine kinases and the c-myc induction pathway. 
Here, we provide evidence for the existence of a third, 
rapamycin-sensitive pathway, whichresults in the in- 
duction of another proto-oncogene, bcl-2. In the hema- 
topoietic cell line BAF-B03, the expression of any two 
of IckF505 (an active form of p56~*), Bcl-2, or c-Myc 
is sufficient to promote transit of the cell cycle, regard- 
less of the activation state of the third pathway. We 
also provide evidence that epidermal growth factor re- 
ceptor signaling may act through the same pathway 
that involves p56 rck. These studies demonstrate a 
novel approach to dissecting signaling pathways regu- 
lating cellular proliferation. 
Introduction 
The functional interleukin-2 receptor (IL-2R) consists of 
three subunits: the IL-2R~, IL-2R~, and IL-2R'y chains, 
none of which contain an intrinsic protein-tyrosine kinase 
(PTK) domain that is the hallmark of other growth factor 
receptors (reviewed by Waldmann, 1989; UIIrich and 
Schlessinger, 1990; Taniguchi and Minami, 1993). We 
have shown previously that expression of the human IL- 
2Rl3 cDNA in BAF-B03, an interleukin-3 (IL-3)-dependent 
murine hematopoietic ell line that expresses IL-2R~z and 
IL-2R~, but not IL-2R~, allows the cells to proliferate in 
response to IL-2. Expression studies with mutant human 
iL-2RI3 cDNAs have revealed that a mutant (S mutant) 
lacking the membrane-proximal cytoplasmic region, 
termed the serine-rich region (S region), cannot transmit 
proliferative signals (Hatakeyama et al., 1989). More re- 
cently, evidence has also been provided demonstrating 
the critical role of the IL-2R~/cytoplasmic region in IL-2 
signaling (Kawahara et al., 1994; Nakamura et al., 1994; 
Nelson et al., 1994), pointing to the importance of coopera- 
tion between the IL-2RI3 and IL-2R~, cytoplasmic domains 
in activating downstream signaling pathways. Despite ex- 
tensive structural and functional studies on the IL-2R com- 
ponents, information is still limited with respect to the na- 
ture and function of the signaling pathways that they 
activate and their target genes. 
Although the IL-2R components themselves lack PTK 
domains, IL-2 stimulation evokes tyrosine phosphorylation 
of intracellular proteins. Notably, the IL-2RJ], chain inter- 
acts both physically and functionally with members of the 
src family of nonreceptor PTKs; p56 ~k is activated by IL-2 
in peripheral blood lymphocytes (PBLs) (Hatakeyama et 
al., 1991; Horak et al., 1991), and other src family mem- 
bers, p59 ~" and p53/56 ~", are activated in an analogous 
manner in BAF-B03-derived cells (Torigoe et al., 1992; 
Kobayashi et al., 1993). The physical interaction between 
p56 rck and IL-2RI3 is mediated by the PTK domain and the 
"acidic region" (A region), respectively (Hatakeyama et al., 
1991). Moreover, the activation of src family PTKs by IL-2 
requires the S region of IL-2R~, and this activation corre- 
lates both with p21 r~" activation (Satoh et al., 1992) and 
with induction of the nuclear proto-oncogenes c-fos and 
c-jun (Shibuya et al., 1992; Minami et al., 1993). Recently, 
it was found that the S region of IL-2RI~ is necessary for 
the binding of two distinct PTKs, Jakl of the Janus family 
PTKs (Miyazaki et al., 1994; Witthuhn et al., 1994) and 
Syk PTK of the Syk/ZAP-70 family PTKs (Minami et al., 
1995) and that the carboxy-terminal region of IL-2R'y is 
necessary for the association of Jak3 (Johnston et al., 
1994; Miyazaki et al., 1994; Russell et al., 1994; Witthuhn 
et al., 1994). However, the role of these PTKs in the activa- 
tion of src family PTKs is still unknown. A mutant form of 
the I L-2R~ chain lacking the A region (A mutant) is deficient 
in activating the p56 jck PTK pathway (Minami et al., 1993), 
but it is still capable of bringing about IL-2-induced prolifer- 
ation when expressed in BAF-B03 cells (Hatakeyama et 
al., 1989). Hence, this raises the issue of whether the p56 ~k 
PTK pathway is involved in any way in IL-2-induced cell 
proliferation. 
Expression studies with mutant IL-2RI~ and epidermal 
growth factor receptor (EGFR) cDNAs in BAF-B03 cells 
revealed the presence of another IL-2R-linked pathway 
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leading to the induction of the nuclear proto-oncogene 
c-myc (Shibuya et al., 1992). This pathway is activated by 
the wild-type and the A mutant but not by the S mutant 
IL-2RI3 chains. EGFR stimulation results in the activation 
of the c-foslc-jun pathway but not ihe c-myc pathway, and 
the c-myc gene must be ectopically expressed for the EGF- 
stimulated cells to progress beyond S phase of the cell 
cycle (Shibuya et al., 1992). Hence, c-myc is a target of 
the IL-2R-mediated signal that is required for the progres- 
sion of the hematopoietic ell cycle. Constitutive xpres- 
sion of c-myc, however, does not cause IL-2 (or IL-3)- 
independent growth of BAF-B03 cells (Shibuya et al., 
1992). Taken together, these observations indicate that 
an additional, as yet unidentified target gene(s) is required 
for bell proliferation. This gene is activated by the IL-2R, 
does not respond to p561ok, and must cooperate with c-myc 
(see Figure 1). 
In the present study, we have reexamined the genes 
involved in BAF-B03 cell proliferation and have adduced 
evidence that bcl-2 is another target gene that mediates 
IL-2-induced cell proliferation, bcl-2 was originally identi- 
fied as an oncogene that is am plified in follicular lymphoma 
(Tsujimoto and Croce, 1986), and it has been extensively 
studied in the context of the inhibition of apoptosis (re- 
viewed by Korsmeyer, 1992). Recently, in addition to bcl-2, 
a bcl-2-related gene, bC/-XL, has also been demonstrated 
EGF 
IL-2R ~ EGFR 
Figure 1. A Model for Three Distinct Signaling Pathways Diverging 
from IL-2R 
This figure summarizes our conclusion that IL-2R stimulation islinked 
to three distinct signaling pathways: the p56 ~k activation pathway 
(which leads to c-fos/c-jun induction), the c-myc induction pathway, and 
the RAP-sensitive, bcl-2 induction pathway. The physical interaction 
between p56 ~ and IL-2R~ requires the A region of the IL-2R~ chain. 
Induction of both the c-myc and bc/-2 genes is mediated by the S 
region of the IL-2R~ chain. The S region of IL-2RI~ is necessary for 
binding of two distinct PTKs, Jakl of the Janus family PTKs and Syk 
PTK of the Syk/ZAP-70 family PTKs. The activation of Syk PTK is 
linked to the induction of the c-myc gene. The H region of IL-2R~ is 
essential for Stat5 activation. The carboxy-terminal region of IL-2R~" 
is necessary for the association with Jak3. The role of Jakl and Jak3 
PTKs in the induction of these preto-oncogenes remains unknown (see 
text for details). 
to inhibit apoptosis (Boise et al., 1993). In contrast, another 
bc/-2-related gene, bax, has been shown to accelerate apop- 
tosis (OItvai et al., 1993). The induction of bcl-2, bcl-xL, or 
bax by IL-2 also requires the S region of the IL-2R~ chain; 
however, only bcl-2 induction is inhibited by rapamycin 
(RAP) (Figure 1). We demonstrate that c-myc and bcl-2 
can cooperate in stimulating cell proliferation, in that coex- 
pression of these two genes leads IL-2 (IL-3)-independent 
cell proliferation. Moreover, we observed that an activated 
form of p561ok carrying a phenylalanine substitution at posi- 
tion 505 (p56~kF505) can cooperate with either c-Myc or 
Bcl-2 in the induction of cell proliferation, providing strong 
evidence supporting a role for p56 ~k in transmitting mito- 
genic signals. We also examined cooperation of either of 
p56~kF505, c-Myc, or Bcl-2 with EGFR stimulation. 
Results 
Induction of bcl-2 Gene by IL-2R 
It has been shown that many hematopoietic ell lines un- 
dergo apoptosis in the absence of cytokine stimulation 
and that the product of the bcl-2 gene prolongs cell survival 
and blocks the apoptosis (reviewed by Korsmeyer, 1992; 
Collins and Rivas, 1993; Vaux, 1993). It has been demon- 
strated also that IL-2 stimulation induces bcl-2 gene ex- 
pression (Deng and Podack, 1993; Otani et al., 1993); 
however, a role for Bcl-2 in IL-2 signaling is not well estab- 
lished. 
To examine if and how the bcl-2 gene is involved in 
IL-2-induced cell proliferation, we first studied bcl-2 mRNA 
induction in BAF-B03 cells expressing wild-type or mutant 
IL-2RI~ chains (i.e., F7, A15, and $25 cells). The F7 cells 
express the wild-type IL-2RI~ chain, the A15 cells express 
a mutant IL-2RI~ chain lacking the A region (amino acid 
residues 313-382), and the $25 cells express an IL-2RI~ 
chain lacking the S region (amino acid residues 267-322). 
It has been previously shown that A15 cells can respond 
to IL-2, albeit less well than F7 cells, whereas $25 cells 
remain unresponsive (Hatakeyama et al., 1989). When 
F7 cells were stimulated with IL-2, bcl-2 mRNA induction 
could be seen after 30 min and reached its peak level after 
12 hr (Figure 2). The induction of the bcl-2 gene was also 
observed in A15 cells after IL-2 stimulation, albeit at a 
lower level than in F7 cells. IL-2 stimulation of $25 cells, 
however, did not result in bcl-2 mRNA expression (Figure 
2). These results indicate that the S region of IL-2R~, which 
is essential for growth signal transmission, is also neces- 
sary for bcl-2 gene induction. The S region was also found 
to be essential for the induction of the bcl-xL and bax genes 
(Figure 2; data not shown). 
bcl.2 Gene Induction Is Sensitive to Rapamycin 
To dissect the IL-2 signaling pathways further, we next 
examined the effects of two immunosuppressive drugs, 
FK506 and RAP, on IL-2-induced proto-oncogene xpres- 
sion. These drugs are known to bind to the same intracellu- 
lar target, but the latter selectively affects the IL-2-depen- 
dent T cell proliferation (Sigal and Dumont, 1992). As 
shown in Figure 3A, neither of the drugs showed any effect 
on the induction of c-los, c-jun, or c-myc genes by IL-2. 
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Figure 2. Expression of the bcl-2 and bCl-XL Genes in BAF-B03- 
Derived Transformants Stimulated with IL-2 
Northern blot analysis of mRNA expression in F7, A15, and $25 cells. 
Total RNA was extracted from cells that had been synchronized (by 
factor starvation for 15 hr) and then stimulated with IL-2 (  nM) for 
various periods. Northern blot analysis was carried out as described 
in Experimental Procedures, and autoradiographs were exposed for 
3 days. Expression of Bcl-2 protein was confirmed by Western blot 
analysis. 
On the other hand, RAP but not FK506 was found to selec- 
tively retard bcl-2 gene induction in a profound manner; 
when F7 cells were stimulated with IL-2 in the presence 
of RAP, the expression of bcl-2 mRNA was delayed for 
6-9 hr. However, RAP showed no effect on the induction 
of bcl-xL and bax mRNAs (Figure 3B; data not shown). 
This suggests that bcl-2 gene induction may be one of the 
targets of RAP. IL-2-induced cell cycle progression as well 
as the induction of some cell cycle stage-specific genes 
was also affected by RAP (data not shown). There is thus 
a close correlation between the IL-2-induced expression 
of the bol-2 gene and progression through the cell cycle. 
bcl.2 Cooperates with EGF Signaling to Elicit Cell 
Proliferation in a c-myc-lndependent Manner 
It has been shown previously that, in BAF-B03-derived 
BER2 cells, c-myc plays a critical role in the progression 
of the cell cycle up to the G21M phase. BER2 cells have 
been engineered to express the human EGFR cDNA, and 
EGF stimulation causes the uptake of [3H]thymidine, but 
does not elicit cell cycle progression, unless c-myc is also 
expressed ectopically (Shibuya et al., 1992). In view of 
the fact that neither the c-myc gene nor the bcl-2 gene is 
induced by EGF stimulation in BER2 cells (Shibuya et al., 
1992; Figure 4A[a]), we tested the ability of bcl-2 to drive 
cell cycle progression in BER2 cells. The human bcl-2 
cDNA was cloned into the expression vector pSVT, and 
the resulting construct pSVBT was cotransfected with the 
hygromycin (hgr) resistance gene into BER2 cells. Three 
clones expressing the transfected bel-2 cDNA, BB3, BB8, 
and BB13, were obtained. These clones did not proliferate 
in a growth factor-independent fashion but could be in- 
duced to proliferate in response to EGF stimulation (Figure 
4B). The BB cells continued to proliferate in response to 
EGF stimulation for at least 1 month. All the hgr + clones 
that were cotransfected with the control vector pSVT failed 
to proliferate in response to EGF (data not shown). 
RNA blotting analysis with the mouse IL-3 cDNA probe 
did not show any IL-3 mRNA expression in BB3, BB8, 
and BB13 cells cultured in the EGF-containing medium. 
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Figure 3. Effects of RAP on the Expression of Proto-Oncogenes and 
bcl-xL Gene Induced by IL-2 
(A) RAP has no effect on the expression of c-los, c-jun, and c-myc 
proto-oncogenes in F7 cells following IL-2 stimulation. Sy chronized 
F7 cells (2 x 10 ~) were preincubated with culture medium or culture 
medium containing either RAP i10 ng/ml, Wyeth-Ayerst Laboratories) 
or FK506 (10 ng/ml, Fujisawa Chemical) for 30 rain and stimulated 
with IL-2 (2 nM) for various periods. Northern blot analysis was carried 
out as described in Figure 2. Autoradiographic exposure times were 
3 h r (c-myc), 3 days (c-fos), and 6 days (c-jun). Membranes were stained 
with methylene blue and stained 28S ribosomal RNA was indicated. 
(S) RAP affects the bcl-2 gene but not bcl-xL gene induction i F7 cells 
by IL-2 stimulation. Synchronized F7 cells (2 x 107) were preincubated 
with culture medium or culture medium containing the respective drugs 
RAP (10 ng/ml) or FK506 (10 ng/ml) for 30 min and stimulated with 
IL-2 (2 nM) for various periods. Autoradiographic exposure times were 
1 day (bcl-2) and 3 days (bc/-XL). Membranes were stained with methy- 
lene blue and stained 28S ribosomal RNA was indicated. 
In addition, supernatant from EGF-stimulated BB3, BB8, 
and BB13 cells did not support he proliferation of BER2 or 
F7 cells (data not shown), indicating that cell proliferation is 
directly mediated by the combination of EGF signaling 
and bcl-2 expression rather than the induction of growth 
stimulatory cytokines. EGF stimulation of BER2 cells did 
not induce the N-myc, bcl-XL, or bax genes (Figure 4A[a]; 
data not shown). Importantly, EGF stimulation of BB3 cells 
did not induce c-myc or N-myc expression (Figure 4A[b]), 
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Figure 4. Expression of the Exogenous bc/-2 Gene in BER2 cells Has 
No Effect on myc Genes Induction but Confers Responsiveness to 
EGF for Cell Proliferation 
(A) (a) Expression of N-myc, bcl-2, and bc/-xL genes in factor-stimu- 
lated BER2 cells. After synchronized BER2 cells were stimulated with 
either EGF or IL-3 for various periods, total RNA extracted from them 
was subjected to Northern blot analysis. 
(b) Expression of c-myc and N-myc genes in factor-stimulated BB3 
cells. After synchronized BB3 cells were stimulated with either EGF 
or IL-3 for various periods, total RNA extracted from them was sub- 
jected to Northern blot analysis. 
(c) Expression of bc/-2 gene in factor-stimulated BM6 cells. After syn- 
chronized BM6 cells were stimulated with either EGF or IL-3 for various 
periods, total RNA extracted from them was subjected to Northern 
blot analysis. 
(B) Proliferation profiles for the factor-stimulated F7,BER2, BM6, BB3, 
BB8, and BB13 cells. Expression of the human Bcl-2 was assessed 
by Western blot analysis and is indicated by the arrow (left inset). 
Synchronized cells were plated at1 x I(P cells/ml in the presence 
of IL-2 (F7 cells) or EGF (others). The number of viable cells was 
counted at various times after factor stimulation and represented on 
a logarithmic s ale. The IL-3R is not shown in the right inset panel. 
suggesting that cell proliferation indeed occurs in the ab- 
sence of myc gene expression. Uptake of [3H]thymidine 
following EGF stimulation was almost the same between 
the parental BER2 cells and the BB3 clone (data not 
shown), suggesting that the expression of the bcl-2 gene 
in these clones did not alter the levels of DNA synthesis. 
Thus, progression of the cell cycle in BAF cells can be 
brought about by the cooperation between EGF signaling 
and either c-myc or bcl-2 expression. 
We also examined whether expression of the endoge- 
nous bcl-2 gene is affected by c-myc expression. The 
BER2-derived BM6 cells constitutively express human 
c-Myc from a transfected expression plasmid containing 
the human c-myc gene, and these cells continued to prolif- 
erate in response to EGF stimulation for at least 1 month 
(Shibuya et al., 1992; data not shown). As shown in Figure 
4A(c), bcl-2 mRNA induction was not detectable in BM6 
cells after EGF stimulation. These observations indicate 
that the c-myc and bcl-2 genes do not affect the expression 
of each other and, therefore, that Bcl-2 and c-Myc indepen- 
dently cooperate with EGFR stimulation to promote the 
i cell cycle progression. 
Cooperation of c-Myc and Bcl-2 Enables BAF-B03 
Cells to Proliferate Independent of Cytokines 
To clarify further the nature of the cooperation between 
Bcl-2 and c-Myc in cell proliferation, we generated cell 
transformants that constitutively express both the human 
c-myc and bcl-2 genes (BMB). The puromycin (puro) resis- 
tance gene and either an expression vector for human 
bcl-2 gene (pSVBT) or control vector (pSVT) were cotrans- 
fected into a cell line, BM6. Whereas the parental BM6 
cells were unable to proliferate unless they were stimu- 
lated with either EGF or IL-3, the puro + clones BMB7, 
BMB17, and BMB23, which express the transfected bcl-2 
gene, could proliferate in a growth factor-independent 
fashion (Figure 5A). BMB cells continued to proliferate in 
the absence of either IL-3 or EGF for at least 1 month at 
a rate approximately 70% of that of the IL-3-stimulated 
parental BER2 cells (data not shown). Evidence for the 
cooperation of c-myc and bcl-2 in lymphoid tumorigenesis 
has been provided previously (Vaux et al., 1988; Strasser 
et al., 1990). 
Cooperation of p56 Ic* PTK with c-Myc or Bcl-2 
for Cell Proliferation 
To address the issue of whether the src family PTKs con- 
tribute to IL-2-induced cell proliferation, we next examined 
whether p56 ~ck could cooperate with either of the two 
known target genes of IL-2 signaling, c-myc and bcl-2. This 
seemed especially important o test since the induction of 
c-myc and bcl-2 genes occurs in A15 cells that express 
a mutant IL-2RI~ deficient for the src family PTK activation 
and since the activation of the src family PTKs, like the 
activation of an artificially introduced EGFR, leads to the 
induction of the c-foslc-jun genes, but not the c-myc and 
bcl-2 genes (Shibuya et al., 1992; Minami et al., 1993; 
Figures 2 and 4A[a]; T. M., unpublished data). 
Mutation of the conserved carboxy-terminal tyrosine 
residue (505) of p56 ~k to phenylalanine (p56~kF505) gives 
rise to a p56 ~k variant with much increased PTK activity 
(Marth et al., 1988). An expression vector for p56~kF505, 
termed pdKCR-IckF505, was constructed and cotrans- 
fected with the hgr resistance gene into BAF-B03-derived 
BER2 cells expressing the human EGFR (Shibuya et al., 
1992). Several transformants expressing the active form 
of p56 ~ck (p56~CkF505) were obtained, and these clones were 
termed BF cells. These BF clones were unable to prolifer- 
ate upon EGF stimulation, indicating the lack (or insuffi- 
ciency) of cooperation between EGFR signaling and p56 ~k 
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Figure 5. Proliferation Profiles for BMB and BF Cells 
(A) Factor independency of the BMB7, BMB17, and BMB23 cells for 
cell growth. Expression f Bcl-2 was assessed by Western blot analysis 
and is indicated by the arrow (left inset). Synchronized BM6, BB3, and 
BMB cells were plated at I x 105 cells/ml in the absence of IL-2, IL-3, 
and EGF. Coexpression of the c-myc and bcl-2 genes in BAF-B03 
cells also resulted in IL-3-independent proliferation. These cells did 
not express detectable levels of IL-3 mRNA by RNA blotting analysis, 
and the culture supernatant was unable to support proliferation f
BER2 or F7 cells, thus indicating that the cell proliferation observed 
is not mediated by endogenously produced growth factors. 
(B) Insufficiency of cooperation between EGF signaling and p56~F505 
in BF cells. Expression of p56~kF505 was assessed by Western blot 
analysis and is indicated by the arrow (left inset). Synchronized BF
cells were plated at 1 x 105 cells/ml in the presence of IL-3 or EGF. 
(Figure 5B). Next, pdKCR-IckF505 was similarly cotrans- 
fected with the puro resistance gene into the BAF-B03- 
derived BM6 and BB3 cells that constitutively express the 
c-myc and bcl-2 genes, respectively. Transformants ex- 
pressing p56~kF505 were obtained, and these were 
termed BMF and BBF cells, respectively. Unlike BF cells, 
both BMF and BBF cells could proliferate in a growth fac- 
tor- independent manner (Figures 6A and 6B). Superna- 
tants from these cells showed no detectable growth factor 
activity (data not shown). These observations indicate that 
p56 p~k activation per se is insufficient o promote cell prolif- 
eration but that it can cooperate with either c-Myc or Bcl-2, 
in a manner analogous to EGFR stimulation. Taken to- 
gether, these observations uggest that the IL-2R is linked 
to at least hree pathways leading to the activation of target 
genes critical for proliferative signal transmission (i.e., the 
src family PTK-linked c-foslc-jun induction pathway, the 
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Figure 6. Factor Independency of the BMF and BBF Cells for Cell 
Growth 
Proliferation profiles for the BM6, BF8, BMF8, BMF9, and BMF16 
cells (A) and the BB3, BF8, BBF9, BBF11, and BBF19 cells (B) in the 
absence of growth factor. Expression f p56*~F505 was assessed by 
Western blot analysis and is indicated by the arrows (left inset). Syn- 
chronized cells were plated at I x 10 s cells/ml in the absence of IL-2, 
IL-3, and EGF. The density of viable cells was counted at various times 
after plating and represented on a logarithmic scale. The IL-3R and 
EGFR are not shown in the right inset panel. 
c-myc induction pathway, and the RAP-sensitive, bcl-2 in- 
duction pathway). 
Suppression of Apoptosis by p56 ~c* 
It has been demonstrated that c-Myc induces apoptosis 
when expressed in the absence of serum or growth factors 
(Askew et al., 1991; Evan et al., 1992; Shi et al., 1992), 
whereas Bcl-2 suppresses it (Bissonnette et al., 1992). 
When BER2, BM6, or BB cells were starved of IL-3 for 
15 hr and the number of viable cells subsequently was 
counted at various intervals, accelerated cell death, ac- 
companied by DNA fragmentation (data not shown), was 
observed in BM 6 cells constitutively expressing the human 
c-myc gene, compared with the parental BER2 cells. In 
contrast, BB cells expressing the human bc/-2 gene could 
survive for a prolonged period relative to BER2 cells (Fig- 
ure 7A). Interestingly, BF cell lines, which express an ac- 
tive form of p56 ~k, could survive in the absence of growth 
factors for a prolonged period relative to the parental BER2 
cells (Figure 7B), and DNA fragmentation was also sup- 
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Figure 7. Regulation of Apoptosis in BAF-BO3 Derived Cells by c-myc, 
bcl-2, or IckF505 Genes Expressed Exogenously 
(A) Cell viability of BER2, BM6, BB3, BB8, and SB13 cells following 
factor deprivation. Synchronized cells were plated at5 x 105 cells/ 
ml in the absence of IL-2, IL-3, and EGF. The density of viable cells was 
counted at various times after plating and represented on a logarithmic 
scale. 
(B) Cell viability of BF5, BF8, and BF9 cells following factor deprivation 
and of the parental BER2 cells with or without EGF stimulation. Syn- 
chronized cells were plated at5 x 105 cells/ml with or without EGF 
stimulation. The number of viable cells was counted at various times 
after plating. The IL-3R and EGFR are not shown in the right inset 
panel. 
pressed (data not shown)i In all BF clones, constitutive 
expression of an active form of p56 j°k did not affect bc/-2 
mRNA expression in the absence of growth factors (data 
not shown). In addition, EGFR stimulation of the parental 
BER2 cells also resulted in suppression of cell death (Fig- 
ure 7B). These observations uggest that, like Bcl-2, p56 ~°k 
activation, as well as EGFR stimulation, results inthe sup- 
pression of apoptosis. 
Discussion 
Many cytokine/cytokine receptor systems have been ex- 
tensively studied in the context of the regulation of cell 
proliferation, particularly in hematopoietic lineages. It has 
been shown that IL-2 induces tyrosine phosphorylation of 
a number of intracellular proteins and that the IL-2R is 
coupled both physically and functionally with multiple non- 
receptor-type PTKs (see Introduction). Despite the identifi- 
cation of such PTKs as downstream mediators of IL-2 sig- 
nal transmission, the nature of their target genes and the 
mechanisms whereby they promote cell cycle progression 
are not fully understood. 
bcl-2 as a Critical Target in IL-2 Signaling 
In the present study, we have provided evidence that, in 
addition to c-foslc-jun and c-myc genes, another proto- 
oncogene (bcl-2) is critical for IL-2 signaling. Analysis of 
BAF-B03-derived clones expressing IL-2RI~ mutants has 
revealed that the induction of both the c-myc and bcl-2 
genes is mediated by the S region of the IL-2RI~ chain. It 
is interesting to note, however, that RAP inhibits bcl-2 gene 
induction but not c-myc gene induction. Hence, our obser- 
vations suggest the presence of a RAP-sensitive intracel- 
lular I L-2 signaling pathway leading to bcl-2 gene induction 
and indicate that the induction pathways for bcl-2 and 
c-myc must diverge at a point beyond that which is medi- 
ated by the S region of the I L-2RI~ chain. Recently, a target 
protein of the RAP-FKBP12 complex, termed FRAP/ 
RAFT1, has been identified that appears to be a mamma- 
lian homolog of the yeast TOR proteins (Brown et al., 1994; 
Sabatini et al., 1994). In view of the fact that both TOR 
and FRAP/RAFT1 proteins show homology to lipid ki- 
nases, one might speculate a link between such kinases 
and the bcl-2 induction. 
As a result of the finding that IL-2-induced bcl-2 gene 
expression is selectively affected by RAP, we established 
F7-derived transformants that constitutively expressed the 
bcl-2 gene and examined the sensitivity of these cells to 
RAP. These clones proliferated better than the parental 
F7 cells in the presence of RAP, but remained partially 
sensitive to RAP (T. M., unpublished data). This may re- 
flect the fact that other biochemical pathways are also 
RAP sensitive. For example, it is known that RAP inhibits 
the activation of p70 s6K (Chung et al., 1992; Kuo et al., 
1992), although at present the relationship between p70 s6K 
activation and bcl-2 induction by IL-2 is unclear. 
Our present findings provide evidence for the impor- 
tance of the bcl-2 proto-oncogene in the regulation of the 
hematopoietic ell cycle, bcl-2 gene induction is selec- 
tively inhibited by RAP, and this correlates with the inhibi- 
tion of cell cycle progression. The cell cycle progresses 
when Bcl-2 expression is accompanied by the expression 
of c-Myc or p5(~CkF505, or by EGFR signaling in BAF-B03- 
derived cells. Thus far, the function of Bcl-2 has been 
extensively studied in the context of suppression of 
apoptosis (reviewed by Korsmeyer, 1992; Schwartz and 
Osborne, 1993; Collins and Rivas, 1993; Vaux, 1993). In 
this context, our results may be interpreted to mean that 
EGFR stimulation or constitutive xpression of c-Myc or 
p56~kF505 leads to simultaneous proliferative and apop- 
totic stimuli and that Bcl-2 suppresses the apoptotic stimu- 
lus, resulting in cell proliferation (see Harrington et al., 
1994). On the other hand, our results suggest another 
possibility: Bcl-2 may also play a role in promoting hemato- 
poietic cell proliferation independent of its role in the inhibi- 
tion of apoptosis. While these two possibilities cannot be 
rigorously distinguished at present, the following observa- 
tions argue for the latter possibility: first, although c-Myc 
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can provide an apoptotic stimulus in BAF cells, both EGFR 
stimulation and p56~kF505 expression, each of which also 
cooperates with Bcl-2, in fact suppress apoptosis (Figure 
7B); second, in BB cells, which express Bcl-2 constitu- 
tively, cyclin D3 mRNA, but not the D1 and D2 mRNAs, 
remains elevated after cytokine deprivation, whereas 
cyclin D3 expression declines in the parental BER2 cells. 
In fact, constitutive xpression of cyclin D3 along with ei- 
ther c-Myc or p56~kF505 expression allows the cytokine- 
independent proliferation of BAF cells. In contrast, cyclin 
D3 and Bcl-2 do not cooperate in this manner (Z.-J. L. and 
T. M., unpublished data). Although further work will be 
required to elucidate the precise mechanism by which 
Bcl-2 affects the cell cycle, the results presented here nev- 
ertheless provide strong evidence that bc/-2 induction by 
IL-2 (or IL-3) is critical for cell cycle progression. 
The Role of p56 ~c* in IL-2-1nduced Cell Proliferation 
Our results with the active form of p56 ~k (p56~kF505) also 
suggest a role for this PTK in the transmission of the 
IL-2-induced mitogenic signal(s). Previously, we had shown 
that the IL-2R~ mutant lacking the acidic region (A mutant) 
fails to associate with and activate the p56 ~k PTK but still 
induces cell proliferation (Hatakeyama et al., 1989; Mi- 
nami et al., 1993). In view of the results presented here, 
it is most likely that cells expressing the A mutant prolifer- 
ate in response to IL-2 stimulation via the induction of 
c-myc and bcl-2 in the absence of p56 ~k activation. Consis- 
tent with this notion is the observation that expression of 
these two genes in combination can render BAF-B03- 
derived cells cytokine independent (Figure 5A). 
Furthermore, coexpression of p56~kF505 with either 
c-Myc or Bcl-2 also promotes cell cycle progression in the 
absence of cytokines, p56~CkF505 expression, however, 
cannot cooperate with EGF stimulation to promote cell 
proliferation (Figure 5B). In addition, p56JCkF505, as well 
as EGFR stimulation, appears to suppress apoptosis upon 
IL-3 deprivation in BAF-B03-derived cells (Figure 7B). We 
infer that the p56 ~k PTK elicits a signal similar or identical 
to that of the EGFR (Figure 1). In fact, it has been shown 
previously that c-fos, c-jun and their family members can 
be activated by a p56~Ck-linked pathway or by EGFR signal- 
ing in BAF-B03 cells (Shibuya et al., 1992). 
Cooperation of the Three Signaling Pathways 
Our results indicate the existence of at least three distinct 
signaling pathways linked to the IL-2R: the p56 ~ck pathway 
that leads to c-foslc-jun induction, the ocl.2 induction path- 
way, and the c-myc induction pathway (Figure 1). Im- 
portantly, none of these pathways affects the activation 
of the other: c-myc gene expression does not affect the 
induction of c-foslc-jun or bcl-2, bc/-2 gene expression 
does not affect c-foslc-jun or c-myc expression, and p56 ~k 
PTK activation does not induce the bcl-2 or c-myc genes 
(Figures 2 and 4A; T. M., unpublished data). 
Expression studies show that a combination of any two 
of the three pathways is sufficient o promote the growth 
of BAF-B03 cells in the absence of cytokines (Figures 5A, 
6A, and 6B). We infer that these three pathways cooperate 
with each other to ensure a full-scale signal transmission 
by IL-2. Consistent with this are the observations that F7 
cells expressing wild-type IL-2RI~ respond to IL-2 better 
than A15 cells that express the IL-2RI~ A mutant (Shibuya 
et al., 1992) and that BMB cells that are able to proliferate 
in the absence of cytokines via the~constitutive expression 
of c-myc and bcl-2 can also respond to EGF as indicated 
by an apparent further increase in the rate of proliferation 
(approximately 1.5-fold; T. M., unpublished data). 
The induction pathways of both the c-myc and bcl-2 
genes are linked to the S region of the IL-2RI3 chain. Re- 
cently, it was found that this region of IL-2RI~ is necessary 
for the binding of Jakl (Miyazaki et al., 1994; Witthuhn et 
al., 1994) and Syk PTK (Minami et al., 1995) and that the 
carboxy-terminal region of I L-2Ry is necessary for associa- 
tion with Jak3 (Johnston et al., 1994; Miyazaki et al., 1994; 
Russell et al., 1994; Witthuhn et al., 1994). It was also 
shown that the activation of Syk PTK results in the induc- 
tion of the c-myc gene (Minami et al., 1995; Figure 1). 
Thus, it is likely that Jakl, Jak3, and Syk are involved in 
the induction of the above proto-oncogenes by IL-2. More 
recently, we have found that IL-2 activates Stat5 in F7 
cells. This Stat5 activation (presumably by the IL-2R- 
associated Jak PTKs) requires the membrane distal H re- 
gion, yet this region is dispensable for IL-2-induced cell 
proliferation (H. Fujii and T. T., unpublished data; Figure 
1; Hatakeyama et al., 1989). Therefore, it is unlikely that 
Stat5 activation is involved in the induction of these proto- 
oncogenes. 
Although in our experimental system activation of two 
out of three pathways was required for cell proliferation, 
it is possible that activation of all three pathways may be 
required for the proliferation of certain cells, e.g., periph- 
eral T cells, depending on the magnitude of induction of 
these target genes. In this regard, it is important o note 
that our inferences have certain limitations, since they are 
primarily based on the results of constitutive gene expres- 
sion assays, whereas the induction of these genes is nor- 
mally of a transient nature. The question of how the signal- 
ing mechanisms operating in BAF-B03 cells relate to other 
cells, such as peripheral T cells, also remains to be ad- 
dressed. Nevertheless, in view of the findings that IL-2- 
induced activation of src family PTKs (the Syk PTK, Jakl 
and Jak3 PTKs) is observed and that all of the target genes 
(c-foslc-jun, c-myc, and bcl-2) are also induced by IL-2, in 
both normal lymphocytes and BAF-B03 derived cells, we 
think that BAF-B03 cells retain similar, if not identical, 
mechanisms of cell proliferation. The fact that RAP, which 
selectively inhibits the bcl-2 gene induction pathway, inhib- 
its the growth of T cells (Sigal and Dumont, 1992) and 
BAF-B03 cells (data not shown) is also consistent with this 
view. At the same time, our results do not exclude the 
possibility of additional IL-2R-linked signaling pathways. 
Experimental Procedures 
Cells and Cell Culture 
BAF-B03, a subclone of BAF3 cell line, is a bone marrow-derived 
mudne IL-3-dependent pro-B cell line (Palacios and Steinmetz, 1985; 
Collins et al., 1992). F7 is a BAF-B03-derived stable transformant clone 
expressing the wild-type human IL-2RI3 chain. A15 and $25 are also 
BAF-B03-derived stable transformant clones expressing the human 
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IL-2R~ mutant lacking the cytoplasmic "acidic" region and the "serine- 
rich" region, respectively (Hatakeyama et al., 1989). BER2 is a BAF- 
B03-derived stable transformant clone that expresses the human 
EGFR. BM6 is a BER2-derived stable transformant clone expressing 
the human c-myc gene ectopically (Shibuya et al., 1992). BB cells 
were established by transfecting the human bc/-2 expression plasmid 
pSVBT (containing the cDNA for human bcl-2 gene; Tsujimoto and 
Croce, 1986) into BER2 cells. BF cells were obtained by transfecting 
the mouse mutant p561=kexpression plasmid pdKCRIckF505 into BER2 
cells. BMB and BMF cells were obtained by transfecting the plasmids 
pSVBT and pdKCRtckF505 into BM6 cells, respectively. BBF cells 
were obtained by transfecting the plasmids pdKCRIckF505 into BB3 
cells. Cells were m aintainsd in RPM I-1640 medium supplemented with 
10O/o (v/v) fetal calf serum and 100/0 (v/v) conditioned medium from 
the WEHI-3B cell line (100/0 WEHI-conditioned medium) as a source 
of IL-3. 
For the analyses of gene expression, cell growth, and cell viability, 
cells were stimulated with either WEHI-conditioned medium (at a final 
concentration of 10o/0 [v/v]) or recombinant human EGF (at a final 
concentration of 10 ng/ml), after cells were synchronized in G1 phase 
by depriving them of cytokines for 15 hr (the cell viability after cytokine 
deprivation was more than 90%). 
DNA Transfection 
Plasmid DNAs were transfected into the cells by an electreporation 
procedure as described previously (Doi et al., 1989). Selection was 
initiated 24 hr after transfection, using 1 mg/ml hygromycin for BB 
or BF cells and 7.5 p.g/ml puromycin for BMB, BMF, or BBF cells. 
Drug-resistant colonies were picked up and subsequently cloned by 
limiting dilution as described previously (Miyazaki et al., 1991). 
Preparation of Probe DNA 
The probe DNAs for c-myc, c-los, and c-jun were prepared as described 
previously (Shibuya et al., 1992), and the probe for human and mouse 
bcl-2 were prepared as follows: human bcl-2, 1.0 kb Xhol fragment 
from the plasmid pSVBT; mouse bcl-2, 2.5 kb Hindlll fragment from 
the plasmid pmbcl3.3 (Negrini et al., 1987). The probe for bax was a 
PCR fragment (nucleotides 215-569) amplified from a murine spleen 
cDNA library. The probe for bcl-xL was the 0.8 kb EcoRI fragment from 
the plasmid pBS-bcl-xL (Boise et al., 1993). 
RNA Extraction and Northern Blot Analysis 
Total cellular RNA from each cell was prepared as described pre- 
viously (Hatakeyama et al., 1989). For RNA blot analysis, 10 p.g of 
total RNA was loaded on each slot (Shibuya etal., 1992). 
Western Blot Analysis 
Cells (2 x 106) were harvested and subjected to the analysis as de- 
scribed previously (Minami et al., 1993). The primary antibodies are 
rabbit anti-p56 ~ antiserum 195.7 or anti-human Bcl-2 monoclonal anti- 
body/100. 
Cell Growth Assay and Viability Assay 
For the cell growth assay, factor-starved cells were cultured at a density 
of 1 x 10 s ceils/ml in RPMI-1640 supplemented with 10% FCS con- 
taining either human EGF (10 ng/ml) or human IL-2 (2 nM) or WEHI- 
conditioned medium (10% [v/v]). Culture media were changed every 
2 days (Miyazaki et al., 1991 ). For the cell viability assay, factor-starved 
cells were cultured in PRMI-1640 supplemented with 10% FCS without 
EGF or cytokines. In both assays, viable cell numbers were determined 
by trypan blue exclusion assay. 
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Note Added in Proof 
The work on Stat5 that is cited as unpublished data by H. Fujii and 
T. T. in the Discussion is now in press: Fujii, H., Nakagawa, Y., Schind- 
ler, U., Kawahara, A., Mori, H., Gouilleux, F., Groner, B., Ihle, J. N., 
Minami, Y., Miyazaki, T., and Taniguchi, T. (1995), Activation of Stat5 
by IL-2 requires a carboxyl-terminal region of the IL-2 receptor ~ chain 
but is not essential for the proliferative signal transmission. Proc. Natl. 
Acad. Sci. USA, in press. 
